AMPK: energy sensor and survival mechanism in the ischemic heart

Qi, Dake; Young, Lawrence H.

doi:10.1016/j.tem.2015.05.010

Cited by 236 publications

(219 citation statements)

References 96 publications

Supporting

Mentioning

206

Contrasting

Unclassified

Order By: Relevance

“…Recent studies showed that restoration of AMPK activation reduced oxidative stress [18, 57], while other studies have linked AMPK stimulation to enhanced oxidative stress [61, 62]. Although the exact relationship between AMPK and oxidative stress is a matter of debate, our results support the notion that restoration of AMPK activation contributes to the amelioration of oxidative stress injury.…”

Section: Discussionsupporting

confidence: 81%

“…AMPK is an “endogenous survival mechanism”[57], and its activation plays a vital role in protecting against diabetes mellitus [58] and myocardial IR injury [14]. AMPK has been reported to exert an infarct-sparing effect by increasing glucose uptake and glucose transporter-4 translocation [14] and precluding cardiomyocyte apoptosis [14, 59].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

AMPK Contributes to Cardioprotective Effects of Pterostilbene Against Myocardial Ischemia- Reperfusion Injury in Diabetic Rats by Suppressing Cardiac Oxidative Stress and Apoptosis

Kosuru

Cai

Kandula³

et al. 2018

Cell Physiol Biochem

View full text Add to dashboard Cite

Background/Aims: Pterostilbene (PT) exerts antidiabetic effects by decreasing blood glucose and modulating lipid metabolism and has been shown to attenuate myocardial ischemia-reperfusion (IR) injury in non-diabetic subjects. However, whether PT can protect against myocardial IR injury in diabetes is unknown. AMPK stimulation is indispensable in offering cardioprotection against myocardial IR injury in diabetes by limiting cardiac apoptosis. Thus, we hypothesized that PT may confer protection against myocardial IR injury in diabetes via AMPK activation. Methods: Sprague-Dawley rats at eight weeks of diabetes induction (induced by an intravenous dose of 65 mg/kg streptozotocin) were administered with vehicle or PT (20 and 40 mg/kg/day, p.o.) for four weeks (starting from week 9 to 12). At the end of week 12, myocardial IR injury was induced by subjecting the diabetic rats to 30 minutes of coronary artery ligation and followed by 2 hours of reperfusion. In in vitro studies, rat primary cardiomyocytes were incubated with low glucose (LG, 5.5 mM) or high glucose (HG, 30 mM) and exposed to 45 minutes hypoxia and 2 hours reoxygenation in the presence or absence of PT (0.5 µM) or the AMPK inhibitor compound C (CC, 5 µM). Results: PT significantly reduced post-ischemic cardiac infarct size, oxidative stress, plasma lactate dehydrogenase (LDH), creatine kinase-MB levels and apoptosis in diabetic rats. In cardiomyocytes, PT decreased hypoxia/ reoxygenation-induced oxidative stress, attenuated LDH and cleaved caspase3/caspase3 ratio and increased Bcl-2/Bax ratio and AMPK phosphorylation. However, CC administration blunted the cardioprotective effects of PT both in vivo and in vitro. Conclusion: Suppressing cardiac oxidative stress and apoptosis via AMPK stimulation may represent a primary mechanism whereby pterostilbene attenuates diabetic myocardial IR injury.

show abstract

Section: Discussionsupporting

confidence: 81%

Section: Discussionmentioning

confidence: 99%

AMPK Contributes to Cardioprotective Effects of Pterostilbene Against Myocardial Ischemia- Reperfusion Injury in Diabetic Rats by Suppressing Cardiac Oxidative Stress and Apoptosis

Kosuru

Cai

Kandula³

et al. 2018

Cell Physiol Biochem

View full text Add to dashboard Cite

show abstract

“…Brian Black (University of California, San Francisco, USA) discussed transcriptional regulation of Prkaa2, which encodes the alpha2 subunit of AMP-activated protein kinase (AMPK), a key therapeutic target in metabolic syndrome, type 2 diabetes and cardioprotection (Qi and Young, 2015). Epigenetic datasets were mined for evolutionary conservation of non-coding sequences within 100 kb of the Prkaa2 start site, and a predicted cardiac enhancer was identified.…”

Section: Transcription Factor Networkmentioning

confidence: 99%

Heartbreak hotel: a convergence in cardiac regeneration

Schneider

2016

Development

View full text Add to dashboard Cite

In February 2016, The Company of Biologists hosted an intimate gathering of leading international researchers at the forefront of experimental cardiovascular regeneration, with its emphasis on 'Transdifferentiation and Tissue Plasticity in Cardiovascular Rejuvenation'. As I review here, participants at the workshop revealed how understanding cardiac growth and lineage decisions at their most fundamental level has transformed the strategies in hand that presently energize the prospects for human heart repair.

show abstract

“…23,24 AMPK signaling is required for angiogenesis in vivo and in vitro. [25][26][27][28] However, there is no information on the consequences of AMPK deletion in arteriogenesis. In this study, we sought to examine the role © 2016 American Heart Association, Inc. Objective-AMP-activated protein kinase (AMPK), an energy and redox sensor, is activated in response to various cellular stresses, including hypoxia, nutrient deprivation, oxidative stress, and fluid shear stress at the site of vessel blockade.…”

mentioning

confidence: 99%

mentioning

confidence: 99%

AMP-Activated Protein Kinase α1 in Macrophages Promotes Collateral Remodeling and Arteriogenesis in Mice In Vivo

Zhu

Zhang

Liu

et al. 2016

ATVB

View full text Add to dashboard Cite

A rteriogenesis is a process of developing collateral circulation through the remodeling and growth of pre-existing collateral arteries after elevated shear stress induced by occlusion.1-3 Arteriogenesis takes place both during embryogenesis and in adult tissues. In the latter case, arteriogenesis, which usually occurs at sites of occlusion or physical disruption of pre-existing arterial conduits such as coronary artery occlusion or femoral artery ligation, plays a vital role in recovery from ischemic insults. 4,5 Understanding the biological factors that affect arteriogenesis will aid in the development of new treatments for patients with arterial stenosis and occlusions.There are 2 commonly considered mechanisms for arteriogenesis: expansion of pre-existing collaterals and de novo arteriogenesis. 2,6,7 Inflammation caused by mechanical hemodynamic forces, such as shear stress and circumferential wall tension, is considered a pivotal trigger and driver for arteriogenesis. 4,[8][9][10][11] Previous studies have shown that monocytes accumulated in the surrounding tissues of collateral vessels alter arterial occlusion. 7,[11][12][13] These macrophages are potent sources of cytokines and growth factors, which are required for natural adaptive arteriogenesis. In spite of a mounting number of putative arteriogenic factors, the exact mechanisms that regulate collateral remodeling are poorly characterized. Furthermore, the processes responsible for arteriogenesis, and its associated molecular signals are poorly understood.AMP-activated protein kinase (AMPK) is a serine/threonine kinase composed of α, β, and γ subunits. 14,15 The α subunit containing the α1 and α2 isoform is the catalytic subunit, whereas the β and γ are regulatory subunits that maintain the stability of the heterotrimer complex. As an energy sensor, AMPK is activated by various cellular stresses, such as hypoxia, nutrient deprivation, and oxidative stress. [16][17][18] Once activated, AMPK phosphorylates and regulates several downstream kinases that reduce energy demand and increase energy supply to maintain whole-body energy homeostasis. 19 In addition, AMPK also regulates many other cellular processes, including cell polarity, cell growth, and proliferation. [20][21][22] Emerging studies have demonstrated that AMPK is activated in response to shear or ischemic stress. 23,24 AMPK signaling is required for angiogenesis in vivo and in vitro. [25][26][27][28] However, there is no information on the consequences of AMPK deletion in arteriogenesis. In this study, we sought to examine the role © 2016 American Heart Association, Inc. Objective-AMP-activated protein kinase (AMPK), an energy and redox sensor, is activated in response to various cellular stresses, including hypoxia, nutrient deprivation, oxidative stress, and fluid shear stress at the site of vessel blockade. The activation of AMPK is involved in angiogenesis. However, it is unknown whether AMPK can influence arteriogenesis. Here, we demonstrate the contribution of macrophage AMPK to arteriogen...

show abstract

AMPK: energy sensor and survival mechanism in the ischemic heart

Cited by 236 publications

References 96 publications

AMPK Contributes to Cardioprotective Effects of Pterostilbene Against Myocardial Ischemia- Reperfusion Injury in Diabetic Rats by Suppressing Cardiac Oxidative Stress and Apoptosis

AMPK Contributes to Cardioprotective Effects of Pterostilbene Against Myocardial Ischemia- Reperfusion Injury in Diabetic Rats by Suppressing Cardiac Oxidative Stress and Apoptosis

Heartbreak hotel: a convergence in cardiac regeneration

AMP-Activated Protein Kinase α1 in Macrophages Promotes Collateral Remodeling and Arteriogenesis in Mice In Vivo

Contact Info

Product

Resources

About